HER2 gene status and the relationship with p21 protein expression in gastric cancer

Chinese-German Journal of Clinical Oncology

Volumn 10, Issue 3, 2011, Pages 162-165

  Li, Yongjie ^a   Wang, Yangkun ^b   Zhang, Xianwei ^b   Li, Fulin ^b   Meng, Nianlong ^b   Yuan, Xutao ^b   Song, Jinsheng ^b  

^a Henan Province People's Hospital of Ruyang County   (China)

^b 150 Central Hospital of PLA   (China)

Author keywords

HER2 gene; p21 protein expression; Stomach cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P21;

ADULT; AGED; ARTICLE; CANCER INVASION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; STOMACH CANCER;

EID: 79955995709     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-011-0760-4     Document Type: Article

References (10)

1. Sebastian S, Settleman J, Reshkin SJ, et al. The complexity of targeting EGFR signaling in cancer: from expression to turnover. Biochim Biophys Acta, 2006, 1766: 120-139. (Pubitemid 44175636)
2. Takai N, Jain A, Kawamata N, et al. 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth. Cancer, 2005, 104: 2701-2708. (Pubitemid 41798280)
3. Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 2007, 13: 4429-4434. (Pubitemid 47219710)
4. Wang YK, Ma NX. Ras oncogene product P21 and the DNA content of atrophic gastritis. Chin J Cancer (Chinese), 1998; 17: 59-60.
5. GAO CF. New technology and clinical laboratory diagnosis. Beijing: People's Medical Publishing House, 2010. 85-112.
6. Roskoski R Jr. The ErbB/HER receptor protein-tyrosine kinases and cancer. Biochem Biophys Res Commun, 2004, 319: 1-11.
7. Stonecypher MS, Chaudhury AR, Byer SJ, et al. Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis. J Neuropathol Exp Neurol, 2006, 65: 162-175.
8. Brabender J, Danenberg KD, Metzger R, et al. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival. Clin Cancer Res, 2001, 7: 1850-1855. (Pubitemid 32994816)
9. Penault-Llorea F, Cayre A. Assessment of HER2 status in breast cancer. Bull Cancer, 2004, 91: 211-215.
10. Hou AJ, Hu Y, Zhou W, et al. Weekly docetaxel, cisplatin and low dose fluorouracil for advanced gastric carcinoma: a randomized clinical trial. Chinese-German J Clin Oncol, 2009, 8: 516-519.